[ad_1]
A&Z Pharmaceuticals and its affiliate, AiPing Pharmaceuticals, received preliminary approval for economic incentives from the Suffolk County Industrial Development Agency for a planned expansion project.
The $6.7 million project includes the conversion of existing Hauppauge warehouse space to a production and manufacturing area to accommodate additional employees and machinery required for the company to transition to prescription pharmaceutical operations, according to an IDA statement.
The project is expected to add 35 jobs to the company’s existing staff of 162.
A&Z currently uses its buildings for domestic sales and as a laboratory, research and development, and manufacturing site for the export of over-the-counter pharmaceuticals, nutraceuticals and prescription pharmaceuticals for sale in the domestic market.
In addition to its over-the-counter medications and nutraceuticals, A&Z’s facility is also FDA-registered to manufacture such prescription drugs as Amitriptyline HCl, which is used to treat depression; Buspirone, which is used to treat generalized anxiety disorder; Meloxicam, which is used for arthritis pain management; and Metformin HCl, which is used to treat diabetes, according to the IDA. The company added 20 FDA prescription drug licenses this year and could add another 10 licenses in 2026.
“We are grateful for the continued partnership of the Suffolk County Industrial Development Agency,” CEO Emma Li Xu, A&Z’s founder, said in the statement. “With the IDA’s critical support, we can move more of our manufacturing and development to Suffolk County.”
Xu started A&Z with four people 30 years ago after working in China, Hong Kong, and Australia, according to the IDA.
“A& Z Pharmaceutical has been a leading manufacturer for 30 years in the global pharmaceutical and growing supplement market,” Kelly Murphy, executive director of the Suffolk IDA, said in the statement. “This project will strengthen A&Z’s manufacturing capabilities and support the continued growth of Suffolk County’s manufacturing and pharmaceutical industry. Projects like this ensure that Suffolk continues to be a hub for innovation, high-quality jobs, and long-term economic vitality.”
[ad_2]
David Winzelberg
Source link